Frequently Asked Questions
Can the Prolia® Co-pay Program MasterCard® be used with mail order and specialty pharmacies?
Yes, the Prolia® Co-pay Program MasterCard® can be used at pharmacies. Patients must simply provide the RxBIN number and member ID that is printed on the card when filling their prescription.
Is there a limit or cap on Prolia® Co-pay Program benefits?
Yes, the Prolia® Co-pay Program will reimburse an eligible patient's combined total deductible, co-pay and/or co-insurance requirements up to $1,500 per calendar year for Prolia® (denosumab). The patient is responsible for costs above this amount.
Why are uninsured, cash-paying patients not eligible for the Prolia® Co-pay Program?
The Prolia® Co-pay Program is intended to help commercially insured patients cover the cost of their co-pay or deductible for Prolia® (denosumab). Uninsured patients requiring assistance may be directed to The Amgen Safety Net Foundation at 1-888-SN-AMGEN (1-888-762-6436) to request assistance. The foundation helps support uninsured patients and certain underinsured patients with financial need who do not have coverage for Prolia® or other Amgen medications, and are not eligible for other support options such as Medicare or Medicaid.
Are there financial assistance options available to people on Medicare or Medicaid?
Amgen Assist® can refer patients, as a courtesy, to independent co-pay foundations. Provided through independent charitable patient assistance programs, eligibility in these foundation programs is based on criteria established by the charity. Amgen has no control over independent, third-party programs. For more information, contact Amgen Assist® at (866)264-2778.
Is annual re-enrollment in the Prolia® Co-pay Program necessary?
Once your specialty pharmacy is enrolled in the Program, there is no need to re-enroll. Patients, however, must re-enroll on a yearly basis. Patients will be sent a letter reminding them to re-enroll. This letter will have a verification code on it that must be used to re-enroll on this site.